STOCK TITAN
  1. Home
  2. Sec-filings
  3. BNTX
  4. [Form 3] BioNTech SE Initial Statement of Beneficial Ownership

BioNTech (BNTX) director Low-Friedrich files Form 3 with no trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

BioNTech SE filed a Form 3 identifying Iris Katharina Low-Friedrich as a director of the company. The filing reports no insider transactions or holdings, with all transaction counts and share amounts shown as zero.

Positive

  • None.

Negative

  • None.
Total buy transactions 0 transactions Form 3 transactionSummary buyCount
Total sell transactions 0 transactions Form 3 transactionSummary sellCount
Net buy/sell shares 0 shares Form 3 transactionSummary netBuySellShares, direction neutral
Form 3 regulatory
""form_type": "3""
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reportingPersons regulatory
""reportingPersons": [ { "name": "Low-Friedrich Iris Katharina""
derivativeSummary financial
""derivativeSummary": []"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Low-Friedrich Iris Katharina
(Last)(First)(Middle)
C/O BIONTECH SE
AN DER GOLDGRUBE 12
(Street)
MAINZD-55131
(City)(State)(Zip)
GERMANY
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
06/26/2026		3. Issuer Name and Ticker or Trading Symbol
BioNTech SE [ BNTX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit List - Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Humza Bokhari, Attorney-in-Fact06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the BioNTech SE (BNTX) Form 3 for Iris Katharina Low-Friedrich show?

The Form 3 for BioNTech SE lists Iris Katharina Low-Friedrich as a director and initial reporting person. It reports no insider transactions or holdings, with all transaction counters and share amounts recorded as zero in this initial statement.

Does the BioNTech SE (BNTX) Form 3 report any insider share purchases or sales?

No, this Form 3 reports no insider share purchases or sales. All transaction-related counts, including buy, sell, acquisition, disposition, and derivative transaction shares, are recorded as zero, indicating no trading activity is disclosed in this initial ownership filing.

Are any derivative securities reported for Iris Katharina Low-Friedrich at BioNTech SE (BNTX)?

No derivative securities are reported for Iris Katharina Low-Friedrich in this Form 3. The derivativeSummary section is empty and derivativeTransactionCount is zero, indicating no options, warrants, or other derivative positions are disclosed in this initial statement of beneficial ownership.

What is the net buy or sell position in the BioNTech SE (BNTX) Form 3?

The Form 3 shows a netBuySellShares value of 0 and a netBuySellDirection described as neutral. This reflects that no insider purchases, sales, or other share-changing transactions are reported for Iris Katharina Low-Friedrich in this initial ownership filing.

Does the BioNTech SE (BNTX) Form 3 indicate any gifts, tax withholding, or restructuring transactions?

No, the Form 3 lists giftCount, taxWithholdingCount, and restructuringCount as zero. GiftShares, taxWithholdingShares, and restructuringShares are also zero, indicating no gifts, tax-related share withholdings, or restructuring-related transfers are disclosed for the reporting person.